Etoposide: all 654 studies that test it

Page 7 of 7. Open to participants first (83), then studies with results posted, then the rest; newest registration first within each.

• Chemotherapy in Treating Patients With Cancer of Unknown Primary OriginStatus unknownNCT00003558Phase 3
• Liposomal Doxorubicin and Etoposide in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal CancerTerminatedNCT00003380Phase 1
• High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Lung CancerStatus unknownNCT00003284Phase 2
• Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain TumorWithdrawnNCT00003273Phase 2
• Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid TumorsCompletedNCT00003269Phase 2
• Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord TumorsCompletedNCT00003141Phase 1
• Surgery in Treating Children With NeuroblastomaCompletedNCT00003119Phase 3
• Combination Chemotherapy in Treating Children With NeuroblastomaCompletedNCT00003093Phase 3
• Combination Chemotherapy With or Without Hyperthermia Therapy in Treating Patients With Soft Tissue SarcomaCompletedNCT00003052Phase 3
• High Dose Chemotherapy, Peripheral Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Acute Myeloid LeukemiaCompletedNCT00002945Phase 3
• Carboplatin, Etoposide, Cyclophosphamide, and Autologous Bone Marrow Transplantation in Patients With Relapsed or Refractory CancerCompletedNCT00002943Phase 2
• Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory Hodgkin's or Non-Hodgkin's LymphomaCompletedNCT00002941Phase 2
• Altretamine and Etoposide in Treating Patients With HIV-Related CancerCompletedNCT00002936Phase 1
• Combination Chemotherapy Plus PSC-833 in Treating Children With Refractory or Relapsed Acute LeukemiaCompletedNCT00002912Phase 1
• Etoposide in Treating Patients With Relapsed Non-Hodgkin's LymphomaCompletedNCT00002880Phase 2
• Etoposide Plus Cisplatin in Treating Patients With Recurrent EpendymomasCompletedNCT00002876Phase 2
• High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced CancerCompletedNCT00002854Phase 1
• Combination Chemotherapy in Treating Patients With LymphomaCompletedNCT00002835Phase 3
• Bone Marrow Transplantation in Treating Patients With LymphomaCompletedNCT00002829Phase 2
• Combination Chemotherapy Followed by Radiation Therapy in Patients With Small Cell Lung CancerCompletedNCT00002822Phase 3
• Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic SyndromeCompletedNCT00002805Phase 2
• Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic SyndromeCompletedNCT00002798Phase 3
• Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Acute Myeloid Leukemia in Second RemissionCompletedNCT00002768Phase 2
• TITLE:Less Intensive Therapy for Children With Non-Hodgkin's LymphomaCompletedNCT00002757Phase 3
• Induction Intensification in Treating Infants With Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedNCT00002756Phase 2
• Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Followed by Surgery and/or Radiation Therapy in Treating Young Patients With Advanced NeuroblastomaCompletedNCT00002740Phase 1
• Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic LeukemiaCompletedNCT00002704Phase 2
• Cyclosporine and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaStatus unknownNCT00002688Phase 2
• Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous LeukemiaCompletedNCT00002674Phase 2
• SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ TransplantCompletedNCT00002657Phase 2
• Interleukin-2 or Observation Following Radiation Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's LymphomaCompletedNCT00002649Phase 3
• Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Ewing's Sarcoma or Primitive Neuroectodermal TumorCompletedNCT00002643Phase 2
• SWOG-9416: Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage III Non-small Cell Lung CancerCompletedNCT00002642Phase 2
• Combination Chemotherapy Alone or With Radiation Therapy in Treating Children With Kidney CancerCompletedNCT00002611Phase 3
• Chemotherapy With or Without Surgery, Radiation Therapy, or Stem Cell Transplantation in Treating Young Patients With Kidney TumorsCompletedNCT00002610Phase 3
• Combination Chemotherapy and Interferon Alfa in Treating Patients With Chronic Myelogenous LeukemiaCompletedNCT00002598Phase 2
• Combination Chemotherapy in Treating Children With LymphomaCompletedNCT00002590Phase 2
• Combination Chemotherapy in Treating Patients With Recurrent or Refractory LeukemiaCompletedNCT00002588Phase 1
• Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's LymphomaCompletedNCT00002565Phase 3
• Combination Chemotherapy in Treating Patients With AIDS-Related LymphomaCompletedNCT00002524Phase 2
• Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Hodgkin's LymphomaCompletedNCT00002522Phase 2
• Combination Chemotherapy and Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's LymphomaCompletedNCT00002521Phase 2
• High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Poor-Prognosis Breast CancerCompletedNCT00002509Phase 1/2
• Combination Chemotherapy Followed by Bone Marrow or Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Germ Cell TumorsCompletedNCT00002508Phase 1/2
• Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic LeukemiaCompletedNCT00002494Phase 2
• Combination Chemotherapy in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma Who Have Not Responded to Anthracycline-Containing Combination ChemotherapyStatus unknownNCT00002488Phase 2
• Combination Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaStatus unknownNCT00002481Phase 2
• Etoposide in Treating Patients With Advanced Ovarian or Cervical CancerTerminatedNCT00002478Phase 2
• Cisplatin and Etoposide Prior to Radiation Therapy in Treating Patients With CNS TumorsCompletedNCT00002472Phase 2
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Peripheral Neuroectodermal Tumors, Ewing's Sarcoma, Wilms' Tumor, or Bone CancerCompletedNCT00002466Phase 2
• Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refractory Hodgkin's Disease or Non-Hodgkin's LymphomaCompletedNCT00002461Phase 2
• Phase II Study of Novantrone(R) (Mitoxantrone) and Etoposide in Patients With HIV Associated Large Cell and Immunoblastic LymphomasCompletedNCT00002003Phase 2
• Phase II Evaluation of Low-Dose Oral Etoposide for the Treatment of Relapsed or Progressed AIDS-Related Kaposi's Sarcoma After Systemic ChemotherapyCompletedNCT00000807Phase 2
• Phase I Study of Weekly Oral VP-16 for AIDS-Associated Kaposi's SarcomaCompletedNCT00000660Phase 1

← Etoposide overview